Proliferation and cell death in oligodendrogliomas

被引:0
作者
Wharton, SB
Hamilton, FA
Chan, WK
Chan, KK
Anderson, JR
机构
[1] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England
[2] Norfolk & Norwich Hosp, Dept Histopathol, Norwich NR1 3SR, Norfolk, England
[3] Hammersmith Hosp, Dept Histopathol, London W12 0HS, England
关键词
oligodendroglioma; apoptosis; Ki-67; proliferation markers;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The rates of cell proliferation and of cell loss influence the growth rate of a tumour and reflect genetic changes. We studied proliferation and apoptosis in oligodendrogliomas and their relationship to progression of the tumours. Thirty-two cases of oligodendroglioma were retrieved spanning a 10-year period. The diagnosis and grade were reviewed and follow-up data obtained. Mitotic index (MI) and apoptotic index (AI) were determined from haematoxylin and eosin (H & E) stained sections. A labelling index (LI) of proliferating cells was obtained using the MIB1 antibody to the Ki-67 antigen. A further index of apoptosis was obtained using in situ end-labelling of DNA strand breaks (TUNEL index, TI). Fourteen cases were graded as II, 18 as III (1993 WHO). LI was significantly higher in grade III than in grade II tumours (P < 0.01) but the difference in apoptotic indices between grades was not significant. There was a significant (P = 0.036) positive correlation between the logarithms of TI and LI. Construction of survival curves demonstrated a significance difference in survival according to histological grade (P < 0.05). Stratification of cases by LI alone did not predict significantly different survival outcomes, and apoptotic indices did not demonstrate a relationship to survival. A positive relationship was demonstrated between proliferation and apoptosis in oligodendrogliomas. The levels of apoptosis observed indicate that this phenomenon may have an important influence on the overall rate of tumour growth.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 38 条
  • [21] 2-5
  • [22] CANCER - A DEATH IN THE LIFE OF P53
    LANE, DP
    [J]. NATURE, 1993, 362 (6423) : 786 - 787
  • [23] LANTOS PL, 1997, GREENFIELDS NEUROPAT, V2, P627
  • [24] LI Y, 1995, AM J PATHOL, V146, P1045
  • [25] OLIGODENDROGLIOMA - HISTOLOGIC EVALUATION AND PROGNOSIS
    MORK, SJ
    HALVORSEN, TB
    LINDEGAARD, KF
    EIDE, GE
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (01) : 65 - 78
  • [26] NAKAGAWA S, 1995, VIRCHOWS ARCH, V427, P175
  • [27] ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis
    Nicholson, DW
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (03) : 297 - 301
  • [28] ONDA K, 1994, CANCER, V74, P1921, DOI 10.1002/1097-0142(19941001)74:7<1921::AID-CNCR2820740716>3.0.CO
  • [29] 2-9
  • [30] Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices
    Ono, Y
    Tamiya, T
    Ichikawa, T
    Kunishio, K
    Matsumoto, K
    Furuta, T
    Ohmoto, T
    Ueki, K
    Louis, DN
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (10) : 1026 - 1031